RxDoctor Payments Data

Farhat Khairallah, MD

Clinical Cardiac Electrophysiology · Tallahassee, FLNPI 1982603965

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 88.3% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $106,026, 7.1 times the $14,938 reported in 2019. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$179,240in general payments, 2019–2025

Across 789 payments — averaging $227.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$158K
  • Abbott$8K
  • Johnson & Johnson$5K
  • Medtronic$4K
  • E.r. Squibb & Sons, L.L.C.$478
  • Penumbra, Inc.$417
  • plus $3K from 24 others
$475,580in research payments, 2019–2025

Across 204 payments — averaging $2331.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$393K
  • Abbott$75K
  • Medtronic$6K
  • Medical Device Business Services, Inc.$2K

What the payments were for

  • Consulting fees$47,59527%
  • Speaking & faculty fees$104,50058%
  • Travel & lodging$10,2876%
  • Food & beverage$16,8599%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$179,240 in reported general payments places this provider in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida

Medicare billing

Part B allowed, 2024
$305,845
Medicare patients
1,203
Services billed
4,959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban2,494$1,971,422
XareltoRivaroxaban458$392,226
EntrestoSacubitril/Valsartan238$195,750
Dofetilide167$43,983
JardianceEmpagliflozin61$34,985
Metoprolol Succinate1,651$31,258
FarxigaDapagliflozin Propanediol32$29,846
Dabigatran EtexilateDabigatran Etexilate Mesylate80$21,881
CorlanorIvabradine Hcl19$13,200
Midodrine Hcl80$6,881
Flecainide Acetate91$6,109
SotalolSotalol Hcl289$5,612
Amiodarone Hcl335$5,431
Diltiazem 24hr Er (Cd)Diltiazem Hcl76$2,961
Potassium Chloride115$1,899

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$249$1,971,4222,494 claims
Johnson & JohnsonXarelto$4,633$392,226458 claims
NovartisEntresto$44$195,750238 claims
AstraZenecaFarxiga$13$29,84632 claims
AmgenCorlanor$141$13,20019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →